Optogenetics: Start-Ups Head For The Light
This article was originally published in Start Up
Optogenetics – technology to control neurons with light – has swept through basic neuroscience research. Efforts to commercialize optogenetics are complex, but a spunky group of start-ups plan to develop therapies using the technology.
You may also be interested in...
The neuromodulation market is growing at a rapid pace and investors and strategics are paying close attention to early-stage innovators. We highlight Cardionomic, Nuviant and Pixium, three young companies that are listening to the brain, fixing broken hearts and making the blind see.
The reorientation of Big Pharma neuroscience R&D toward a biology-driven approach is creating new hope for the treatment of psychiatric disorders.